Sustained hyperglycemia among patients with diabetes: What matters when action is needed?

Diabetes Care

Volumn 32, Issue 8, 2009, Pages 1447-1452

  Lafata, Jennifer E ^a   Dobie, Elizabeth A ^a   Divine, George W ^a   Ulcickas Yood, Marianne E ^b   McCarthy, Bruce D ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Allina Hospitals & Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; SULFONYLUREA;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH INSURANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PREVALENCE; PRIMARY MEDICAL CARE; RACE DIFFERENCE; RISK ASSESSMENT; SUSTAINED HYPERGLYCEMIA; THERAPY DELAY;

ADMINISTRATION, ORAL; ADULT; AGED; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; GROUP PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MICHIGAN; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SULFONYLUREA COMPOUNDS; YOUNG ADULT;

EID: 68149139748     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-2028     Document Type: Article

References (24)

1. Wetzler HP, Snyder JW. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care 2000;23:1637-1641 (Pubitemid 30812636)
2. Grant RW, Cagliero E, Dubey AK, Gildesgame C, Chueh HC, Barry MJ, Singer DE, Nathan DM, Meigs JB. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med 2004;21: 150-155 (Pubitemid 38221814)
3. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005;28:337-442
4. Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care 2007;30:807-812 (Pubitemid 46556571)
5. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 2005;28:600-606
6. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006;144:475-484 (Pubitemid 46780670)
7. Yood MU, Lafata JE, Koro C, Wells KE, Pladevall M. Time to pharmacotherapy change in response to elevated HbA1c test results. Curr Med Res Opin 2006;22: 1567-1574 (Pubitemid 44297435)
8. Holman R, Paul S, Bethel M, Matthews D, Neil H. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
9. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49): UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999;281:2005-2012
10. Vine MF, Degnan D, Hanchette C. Geographic information systems: their use in environmental epidemiologic research. Environ Health Perspect 1997;105:598-605 (Pubitemid 27405808)
11. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40: 1280-1288
12. SAS Institute Inc.: SAS/STAT Users Guide. Cary, NC, SAS Institute Inc., 2004
13. Benefit-based copays in the real world: the employer perspective. Am J Manag Care 2006;12:S353-S358 (Pubitemid 44865054)
14. Fuhrmans V: New Tack on Copays: Cutting Them. Employers, Insurers Bet That Covering More of the Cost of Drugs Can Save Money Over the Long Term for Chronic Conditions. The Wall Street Journal. 8 May 2007
15. Berlowitz DR, Ash AS, Glickman M, Friedman RH, Pogach LM, Nelson AL, Wong AT. Developing a quality measure for clinical inertia in diabetes care. Health Serv Res 2005;40:1836-1853 (Pubitemid 41814237)
16. Sperl-Hillen J, O'Connor PJ, Carlson RR, Lawson TB, Halstenson C, Crowson T, Wuorenma J. Improving diabetes care in a large health care system: an enhanced primary care approach. Jt Comm J Qual Improv 2000;26:615-622
17. Okazaki K, Goto M, Yamamoto T, Tsujllm S, Ishll H. Barriers and facilitators in relation to starting insulin therapy in type 2 diabetes (Abstract). Diabetes 1999;48:A1319
18. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005;28:2543-2545 (Pubitemid 41384310)
19. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-2679
20. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol 2001;57:457-478 (Pubitemid 32247035)
21. O'Connor PJ. Improving diabetes care by combating clinical inertia. Health Serv Res 2005;40:1854-1861 (Pubitemid 41814238)
22. Karter AJ, Moffet HH, Liu J, Parker MM, Ahmed AT, Ferrara A, Selby JV. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care 2005;11:262-270 (Pubitemid 40569749)
23. Brown JB, Nichols GA. Slow response to loss of glycemic control in type2diabetes mellitus. Am J Manag Care 2003;9:213-217
24. Schectman JM, Schorling JB, Nadkarni MM, Voss JD. Can prescription refill feedback to physicians improve patient adherence? Am J Med Sci 2004;327:19-24